SEC-sourced researchBeta
EVH
Evolent Health, Inc.
Company comparison ↗
Data passport
- CIK
- 0001628908
- Exchange
- NYSE
- Business activity
- — · SIC 8741
- Financial inputs
- 6/6
- Filing date
- Sep 8, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 1,963,896,000.0000 | Feb 25, 2026 |
| December 2024 | 2,554,741,000.0000 | Feb 25, 2026 |
| December 2025 | 1,876,229,000.0000 | Feb 25, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,876,229,000.0000 | -534,510,000.0000 | 38,843,000.0000 | 1,899,236,000.0000 | 1,484,042,000.0000 | Feb 25, 2026 |
| December 2024 | 2,554,741,000.0000 | -61,623,000.0000 | 18,765,000.0000 | 2,544,411,000.0000 | 1,352,979,000.0000 | Feb 25, 2026 |
| December 2023 | 1,963,896,000.0000 | -113,040,000.0000 | 142,582,000.0000 | — | — | Feb 25, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.88B | December 2025 | Feb 25, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.55B | December 2024 | Feb 25, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$534.51M | December 2025 | Feb 25, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $38.84M | December 2025 | Feb 25, 2026 | 10-K |
| Total assetsAssets | $1.9B | December 2025 | Feb 25, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.48B | December 2025 | Feb 25, 2026 | 10-K |